Publications by authors named "H Bazin"

Dentigerous cysts, if left untreated, can grow significantly and weaken the mandible, posing risks of pathological or iatrogenic fracture. Treatment options may include decompression, marsupialization, and enucleation, which are available, with the choice being multifactorial and tailored to each case. This article describes the management of two complex dentigerous cysts at risk of fracture, one about an 84-year-old woman and the second about a 41-year-old man.

View Article and Find Full Text PDF
Article Synopsis
  • * The study presents amine-grafted silica nanoparticles (A-SNP) as a versatile platform for co-delivering TLR7/8 agonists and the influenza antigen H7, showing over 90% adsorption efficiency.
  • * In tests, A-SNP formulations improved immune responses in mice, leading to stronger H7-specific antibodies and T-cell responses without negative side effects, indicating a promising new vaccine strategy.
View Article and Find Full Text PDF

Opioid use disorders (OUD) and opioid-related fatal overdoses are a public health concern in the United States. Approximately 100,000 fatal opioid-related overdoses occurred annually from mid-2020 to the present, the majority of which involved fentanyl or fentanyl analogs. Vaccines have been proposed as a therapeutic and prophylactic strategy to offer selective and long-lasting protection against accidental or deliberate exposure to fentanyl and closely related analogs.

View Article and Find Full Text PDF
Article Synopsis
  • Infection is a leading cause of death in infants, but the potential benefits of vaccines are not fully utilized, and new adjuvants are needed to optimize immunization strategies for this age group.
  • Currently, only a limited number of adjuvants are used in approved vaccines, but recent advancements in Toll-like receptor (TLR) agonists, specifically TLR7/8, offer new options for enhancing vaccine effectiveness.
  • The study highlights the development of a TLR7/8 adjuvant that significantly improves immune responses in neonatal mice, suggesting it may lead to more effective vaccination against pertussis and potentially other pathogens in infants.
View Article and Find Full Text PDF

Despite the ease of production and improved safety profiles of recombinant vaccines, the inherently low immunogenicity of unadjuvanted proteins remains an impediment to their widespread adoption. The covalent tethering of TLR agonists to antigenic proteins offers a unique approach to co-deliver both constituents to the same cell-enhancing vaccine efficacy while minimizing reactogenicity. However, the paucity of simple and effective linker chemistries continues to hamper progress.

View Article and Find Full Text PDF